Cargando…

Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development

Detalles Bibliográficos
Autores principales:	Del Gatto, Annarita, Cobb, Steven L., Zhang, Jinqiang, Zaccaro, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633406/ https://www.ncbi.nlm.nih.gov/pubmed/34869243 http://dx.doi.org/10.3389/fchem.2021.802120

Ejemplares similares

Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
por: Staśkiewicz, Agnieszka, et al.
Publicado: (2021)

Editorial of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”
por: Cai, Jianfeng, et al.
Publicado: (2021)

An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis
por: Del Gatto, Annarita, et al.
Publicado: (2021)

Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery
por: Lee, Yeon Sun
Publicado: (2022)

Macrocyclization strategies for cyclic peptides and peptidomimetics
por: Bechtler, Clément, et al.
Publicado: (2021)

Human defensin-inspired discovery of peptidomimetic antibiotics
por: Luo, Gan, et al.
Publicado: (2022)

Editorial: In silico Methods for Drug Design and Discovery
por: Brogi, Simone, et al.
Publicado: (2020)

Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation
por: Alcaro, Stefano, et al.
Publicado: (2019)

Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
por: Molchanova, Natalia, et al.
Publicado: (2017)

Editorial: Advances in green synthesis for drug discovery
por: Allais, Florent, et al.
Publicado: (2023)

Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators
por: Olson, Keith M., et al.
Publicado: (2021)

Editorial: Computational Approaches in Drug Discovery and Precision Medicine
por: Huang, Zunnan, et al.
Publicado: (2021)

Editorial: Protein–Protein Interactions: Drug Discovery for the Future
por: Rapposelli, Simona, et al.
Publicado: (2021)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

Editorial: Current approaches in infectious disease drug discovery
por: Silva-Jr, Floriano P., et al.
Publicado: (2022)

Combating amyloid-induced cellular toxicity and stiffness by designer peptidomimetics
por: Konar, Mouli, et al.
Publicado: (2021)

Peptoids: Smart and Emerging Candidates for the Diagnosis of Cancer, Neurological and Autoimmune Disorders
por: Giorgio, Anna, et al.
Publicado: (2023)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Editor Profiles: Guest Editors of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”()
Publicado: (2021)

Nucleobase-modified nucleosides and nucleotides: Applications in biochemistry, synthetic biology, and drug discovery
por: Berdis, Anthony
Publicado: (2022)

Sub-stoichiometric inhibition of IAPP aggregation: a peptidomimetic approach to anti-amyloid agents
por: Maity, Debabrata, et al.
Publicado: (2020)

Editorial: Computational Drug Discovery for Targeting of Protein-Protein Interfaces
por: Meli, Massimiliano, et al.
Publicado: (2021)

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery
por: Ibrahim, Hany S., et al.
Publicado: (2021)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites
por: Olaleye, Tayo O., et al.
Publicado: (2014)

G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
por: Boyhus, Lotte-Emilie, et al.
Publicado: (2018)

The sustainable synthesis of peptidomimetics via chemoenzymatic tandem oxidation–Ugi reaction
por: Madej, Arleta, et al.
Publicado: (2018)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Peptides and Peptidomimetics for Antimicrobial Drug Design
por: Mojsoska, Biljana, et al.
Publicado: (2015)

Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022)

Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia
por: Albert, Lea, et al.
Publicado: (2017)

A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds
por: Isidro-Llobet, Albert, et al.
Publicado: (2015)

Chemical Platform for the Preparation of Synthetic Orally Active Peptidomimetics with Hemoregulating Activity
por: Deigin, Vladislav, et al.
Publicado: (2016)

Stimulated Raman scattering microscopy: an emerging tool for drug discovery
por: Tipping, W. J., et al.
Publicado: (2016)

Discovery of Potent Peptidomimetic Antagonists for Heterochromatin Protein 1 Family Proteins
por: Lamb, Kelsey N., et al.
Publicado: (2021)

Effect of the array of amines on the transfection efficiency of cationic peptidomimetic lipid molecules into neural cells
por: Yu, Xiang, et al.
Publicado: (2022)

Differential copper-guided architectures of amyloid β peptidomimetics modulate oxidation states and catalysis
por: Ghosh, Debasis, et al.
Publicado: (2022)

Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II
por: Morra, Giulia, et al.
Publicado: (2023)

Editorial: Improving antimicrobial peptides translational potential through peptidomimetics
por: Angeles-Boza, Alfredo M., et al.
Publicado: (2023)

RGDechi-hCit: αvβ3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells
por: Capasso, Domenica, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n0bgml1nt9cjmcnnhdhfb8df40